HEALTH CATALYST INC - NOTE 2.500% 4/1

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Debt / NOTE 2.500% 4/1
Market price (% of par)
91.75%
Total 13F principal
$211,495,193
Principal change
+$1,522,657
Total reported market value
$219,620,438
Number of holders
22
Value change
+$6,871,383
Number of buys
12
Number of sells
12

Institutional Holders of HEALTH CATALYST INC - NOTE 2.500% 4/1 as of Q1 2023

As of 31 Mar 2023, HEALTH CATALYST INC - NOTE 2.500% 4/1 was held by 22 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $211,495,193 in principal (par value) of the bond. The largest 10 bondholders included Linden Advisors LP, LAZARD ASSET MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MARSHALL WACE, LLP, Opti Capital Management, LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., CAPSTONE INVESTMENT ADVISORS, LLC, ADVENT CAPITAL MANAGEMENT /DE/, and WOLVERINE ASSET MANAGEMENT LLC. This page lists 22 institutional bondholders reporting positions for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.